William Thies News
-
Baxter International Inc.’s Gammagard, used to treat immune system disorders, halted the progression of Alzheimer’s disease for as long as three years in a trial of 16 patients, researchers said.
-
Older adults who have too much, too little or restless sleep have an increased risk for Alzheimer’s disease, according to studies that suggest doctors note these conditions in patients for follow-up evaluations.
-
A slow or uneven gait in older patients may be more than the effect of advancing age, according to three studies that found walking disorders in the elderly also may be early signs of Alzheimer’s disease.
-
In separate probes into the roots of Alzheimer’s, scientists have uncovered a rare gene mutation that keeps plaque from forming in the brain and found the disease may take hold 25 years before symptoms appear.
-
When 70-year-old Bill Price signed on in 2006 to become one of the early testers of the Alzheimer’s drug bapineuzumab, he held high hopes the injections would stop the disease that was starting to claim his memory.
-
Over the past 18 months, 81-year-old Bill Bunnell has visited the doctor a half-dozen times to take memory tests, provide blood samples, and undergo a spinal tap and imaging scans. It’s all part of the most extensive study ever conducted on Alzheimer’s.
-
Head injuries may more than double the risk of dementia in military veterans, a study found.
-
Almost 15 million people care for U.S. patients with Alzheimer’s disease and dementia, providing 17 billion hours of unpaid help valued at $202.6 billion, an advocacy group said.
-
Eli Lilly & Co. said patients with Alzheimer’s disease whose conditions worsened upon taking the experimental drug semagacestat didn’t improve after dosing was halted.
-
Doctors should screen for Alzheimer’s as soon as mild cognitive symptoms occur and encourage genetic testing for patients, according to the first new guidelines for the disease in almost three decades.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page